Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Droxicam | HCID 65679 | — |
| Reactant | Lawesson's reagent | HCID 87949 | — |
| Solvent | O-Xylene | HCID 7237 | — |
| Product | HCID 13276783 | HCID 13276783 | — |
Reaction Steps
8.1 g (0.02 mols) of 2,4-bis-(4-methoxyphenyl)-2,4-dithioxo-1,3,2,4-dithiadiphosphetane and 3.6 g (0.01 mol) of 5-methyl-3-(2-pyridyl)-2H,5H-1,3-oxazino[5,6-c][1,2]benzothiazine-2,4-(3H)dione-6,6-dioxide in 80 ml of xylene are maintained under reflux at 140° C. for 36 hours. The mixture is subjected to chromatography over a column containing silica gel as the stationary phase by initially eluting with xylene and then with chloroform. 1.4 g (38%) of 5-methyl-3(2-pyridyl)-2H,5H-1,3-oxazino[5,6-c][1,2]benzothiazine2(3H)thione-4-one-6,6-dioxide corresponding to the following formula are recovered from the chloroform solution: ##STR9##
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04563452 |
|---|
| Source dataset | uspto-grants-1986_01 |
|---|
| ORD ID | ord-4ae110a0483d43c0893655e3e4b2682b |
|---|
| Source note | uspto-grants-1986_01 |
|---|